These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preparation and in vitro screening of symmetrical bis-isoquinolinium cholinesterase inhibitors bearing various connecting linkage--implications for early Myasthenia gravis treatment. Musilek K, Komloova M, Holas O, Hrabinova M, Pohanka M, Dohnal V, Nachon F, Dolezal M, Kuca K. Eur J Med Chem; 2011 Feb; 46(2):811-8. PubMed ID: 21236521 [Abstract] [Full Text] [Related]
4. The preparation, in vitro screening and molecular docking of symmetrical bisquaternary cholinesterase inhibitors containing a but-(2E)-en-1,4-diyl connecting linkage. Musilek K, Pavlikova R, Marek J, Komloova M, Holas O, Hrabinova M, Pohanka M, Dohnal V, Dolezal M, Gunn-Moore F, Kuca K. J Enzyme Inhib Med Chem; 2011 Apr; 26(2):245-53. PubMed ID: 21406034 [Abstract] [Full Text] [Related]
6. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase. Huang L, Luo Z, He F, Lu J, Li X. Bioorg Med Chem; 2010 Jun 15; 18(12):4475-84. PubMed ID: 20471843 [Abstract] [Full Text] [Related]
11. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors. Sheng R, Lin X, Zhang J, Chol KS, Huang W, Yang B, He Q, Hu Y. Bioorg Med Chem; 2009 Sep 15; 17(18):6692-8. PubMed ID: 19692250 [Abstract] [Full Text] [Related]
12. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F. Toxicology; 2009 May 17; 259(3):133-9. PubMed ID: 19428953 [Abstract] [Full Text] [Related]
13. Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early myasthenia gravis treatment. Komloova M, Musilek K, Dolezal M, Gunn-Moore F, Kuca K. Curr Med Chem; 2010 May 17; 17(17):1810-24. PubMed ID: 20345342 [Abstract] [Full Text] [Related]
14. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. Carolan CG, Dillon GP, Gaynor JM, Reidy S, Ryder SA, Khan D, Marquez JF, Gilmer JF. J Med Chem; 2008 Oct 23; 51(20):6400-9. PubMed ID: 18817366 [Abstract] [Full Text] [Related]
17. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors. Alptüzün V, Kapková P, Baumann K, Erciyas E, Holzgrabe U. J Pharm Pharmacol; 2003 Oct 23; 55(10):1397-404. PubMed ID: 14607022 [Abstract] [Full Text] [Related]
18. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives. Rampa A, Bisi A, Valenti P, Recanatini M, Cavalli A, Andrisano V, Cavrini V, Fin L, Buriani A, Giusti P. J Med Chem; 1998 Oct 08; 41(21):3976-86. PubMed ID: 9767635 [Abstract] [Full Text] [Related]